🟢 Quantum BioPharma Ltd. is trading 7.0% up today as shares rebound from FDA clinical hold selloff

Quantum BioPharma Ltd. is trading at $5.47 (7.0% up) in pre-market, rebounding modestly after heavy selling linked to a recent FDA clinical hold.

• The stock plunged following the June 2, 2026, announcement that the FDA placed a clinical hold on the Lucid-MS IND application, a key multiple sclerosis program.
• The regulatory setback has weighed heavily on market sentiment, driving steep declines over the last several trading sessions.
• Today’s price action appears to be a partial stabilization following the recent shock rather than a reaction to new company news.